Skip to main
  1. Stocks
  2. American Healthcare REIT Inc
  3. Forecast
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 45%
Buy 55%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT is favored because its RIDEA-heavy portfolio, led by Trilogy and traditional SHOP, is delivering strong organic growth from occupancy gains, pricing power, and margin expansion, with ISHC and SHOP representing about 60% and 22% of NOI as of 2Q26. It is also benefiting from an active acquisition program, with $1.4 billion completed YTD, an additional ~$1.3 billion awarded pipeline, and large investments expected to be accretive at high-5% to low-6% initial yields while supported by strong pre-funded equity. With net debt-to-EBITDA at 1.6x post transactions and an estimated 100-150 bps investment spread, the balance sheet appears flexible enough to sustain external growth and drive elevated AFFO growth through 2028.

Bears say

American Healthcare REIT is viewed negatively because its cash flows are unusually concentrated in Trilogy, which generated about 42% of 2024 NOI, while roughly 24% of total NOI comes from SNF operational cash flows that are more volatile and heavily dependent on government reimbursement. The thesis is further pressured by the risk of Medicaid cuts or the repeal of Indiana’s IGT add-on rates, which could lower Trilogy’s Medicaid rates, slow the investment pace, and trim the 7-YR AFFO CAGR by 500 bps to 10%+. As a result, the REIT faces heightened operational and regulatory risk, limited upside, and greater sensitivity to labor, reimbursement, and transparency around headwinds.

AHR has been analyzed by 11 analysts, with a consensus rating of Buy. 45% of analysts recommend a Strong Buy, 55% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

AHR Analyst Forecast & Price Prediction

Get the latest AHR stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in AHR

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 11 analysts, AHR has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $64.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $64.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


AHR Analyst Forecast & Price Prediction

Get the latest AHR stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in AHR

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover AHR stock data and trends